BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 11967114)

  • 1. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome.
    Salomonsson S; Larsson P; Tengnér P; Mellquist E; Hjelmström P; Wahren-Herlenius M
    Scand J Immunol; 2002 Apr; 55(4):336-42. PubMed ID: 11967114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome.
    Amft N; Curnow SJ; Scheel-Toellner D; Devadas A; Oates J; Crocker J; Hamburger J; Ainsworth J; Mathews J; Salmon M; Bowman SJ; Buckley CD
    Arthritis Rheum; 2001 Nov; 44(11):2633-41. PubMed ID: 11710719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CX3CL1 and CX3CR1 expression in tertiary lymphoid structures in salivary gland infiltrates: fractalkine contribution to lymphoid neogenesis in Sjogren's syndrome.
    Astorri E; Scrivo R; Bombardieri M; Picarelli G; Pecorella I; Porzia A; Valesini G; Priori R
    Rheumatology (Oxford); 2014 Apr; 53(4):611-20. PubMed ID: 24324211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome.
    Barone F; Bombardieri M; Manzo A; Blades MC; Morgan PR; Challacombe SJ; Valesini G; Pitzalis C
    Arthritis Rheum; 2005 Jun; 52(6):1773-84. PubMed ID: 15934082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
    Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
    Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.
    Aqrawi LA; Ivanchenko M; Björk A; Ramírez Sepúlveda JI; Imgenberg-Kreuz J; Kvarnström M; Haselmayer P; Jensen JL; Nordmark G; Chemin K; Skarstein K; Wahren-Herlenius M
    Clin Exp Immunol; 2018 Jun; 192(3):259-270. PubMed ID: 29453859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue.
    Hansen A; Lipsky PE; Dörner T
    Arthritis Res Ther; 2007; 9(4):218. PubMed ID: 17697366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic lymphoid neogenesis and lymphoid chemokines in Sjogren's syndrome: at the interplay between chronic inflammation, autoimmunity and lymphomagenesis.
    Bombardieri M; Pitzalis C
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1989-96. PubMed ID: 22208651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases.
    Aust G; Sittig D; Becherer L; Anderegg U; Schütz A; Lamesch P; Schmücking E
    Eur J Endocrinol; 2004 Feb; 150(2):225-34. PubMed ID: 14763921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma.
    Pontarini E; Murray-Brown WJ; Croia C; Lucchesi D; Conway J; Rivellese F; Fossati-Jimack L; Astorri E; Prediletto E; Corsiero E; Romana Delvecchio F; Coleby R; Gelbhardt E; Bono A; Baldini C; Puxeddu I; Ruscitti P; Giacomelli R; Barone F; Fisher B; Bowman SJ; Colafrancesco S; Priori R; Sutcliffe N; Challacombe S; Carlesso G; Tappuni A; Pitzalis C; Bombardieri M
    Ann Rheum Dis; 2020 Dec; 79(12):1588-1599. PubMed ID: 32963045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome.
    Salomonsson S; Jonsson MV; Skarstein K; Brokstad KA; Hjelmström P; Wahren-Herlenius M; Jonsson R
    Arthritis Rheum; 2003 Nov; 48(11):3187-201. PubMed ID: 14613282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation.
    Xanthou G; Polihronis M; Tzioufas AG; Paikos S; Sideras P; Moutsopoulos HM
    Arthritis Rheum; 2001 Feb; 44(2):408-18. PubMed ID: 11229473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
    Zhao J; Kubo S; Nakayamada S; Shimajiri S; Zhang X; Yamaoka K; Tanaka Y
    Mod Rheumatol; 2016 Sep; 26(5):716-24. PubMed ID: 26706891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LTBR-pathway in Sjogren's syndrome: CXCL13 levels and B-cell-enriched ectopic lymphoid aggregates in NOD mouse lacrimal glands are dependent on LTBR.
    Fava RA; Browning JL; Gatumu M; Skarstein K; Bolstad AI
    Adv Exp Med Biol; 2011; 691():383-90. PubMed ID: 21153342
    [No Abstract]   [Full Text] [Related]  

  • 15. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization.
    Barone F; Bombardieri M; Rosado MM; Morgan PR; Challacombe SJ; De Vita S; Carsetti R; Spencer J; Valesini G; Pitzalis C
    J Immunol; 2008 Apr; 180(7):5130-40. PubMed ID: 18354239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discerning the kinetics of autoimmune manifestations in a model of Sjögren's syndrome.
    Karnell JL; Mahmoud TI; Herbst R; Ettinger R
    Mol Immunol; 2014 Dec; 62(2):277-82. PubMed ID: 24907930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate.
    Bombardieri M; Barone F; Pittoni V; Alessandri C; Conigliaro P; Blades MC; Priori R; McInnes IB; Valesini G; Pitzalis C
    Arthritis Res Ther; 2004; 6(5):R447-56. PubMed ID: 15380044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function.
    Schaerli P; Willimann K; Lang AB; Lipp M; Loetscher P; Moser B
    J Exp Med; 2000 Dec; 192(11):1553-62. PubMed ID: 11104798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue.
    Carlsen HS; Baekkevold ES; Johansen FE; Haraldsen G; Brandtzaeg P
    Gut; 2002 Sep; 51(3):364-71. PubMed ID: 12171958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of germinal center-like structures in patients with Sjögren's syndrome.
    He J; Jin Y; Zhang X; Zhou Y; Li R; Dai Y; Sun X; Zhao J; Guo J; Li Z
    Int J Rheum Dis; 2017 Feb; 20(2):245-251. PubMed ID: 28556615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.